NEW
Lutathera

Lutathera Indications/Uses

Manufacturer:

Novartis

Distributor:

Global Medical Solutions
Full Prescribing Info
Indications/Uses
Lutathera is indicated for the treatment of unresectable or metastatic, progressive, well differentiated (G1 and G2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (GEP-NETs) in adults.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in